This can be a painful area especially if you're new to bringing in CBD within your business. Here are my TOP 5vquick and helpful starting points. I. If you plan to retail or offer services check out the new Hemp Regulatory updates that require age 21+ signage 2. If you retail or offer services with CBD check/verify with your states department of Agriculture and confirm as well with your states Department of Health. Some states DO require a retail permit that is renewed each year to offer CBD and retail within your establishment 3. Don't Be Detoured! The added value for your customers and clients and the additional revenue streams is FAR greater than the permit fees and worth the "process." 4. .3% THC is scheduled to be prohibited come November 2026. Don't delay! Some states have adopted the policy already while they work to develop the structure to enforce the Hemp Regulation changes come November. 5. Broad Spectrum Hemp Derived products will live in the non cannabis CBD market and it will thrive in our industry.

When the signal of communication is ●Pain and Chronic ●Sleep Disruption and Chronic ●Mood Imbalance (frequently) ●Hormonal Irregularities ●High Inflammation Response ●Slow Gut Motility ●Slow Athletic Recovery These are all signs of a low functioning Endocannabinoid System. Hemp-derived CBD formulated in topicals are one effective way to "Tone" the ECS offering cross functional dynamic support 👏

Did you know your body contains it's own Endocannabinoids via the Endocannabinoid System? Sort of like how your body makes it's own antioxidants. Compounds found in Hemp are called Phytocannabinoids. (Plant versions of the exact ones your body has).... And guess what! These specific plant compounds in hemp are mysteriously able to "engage" with the specified receptor sites found in the layers of the skin and documented in organs all throughout the body. This receptor site engagement between phytocannabinoids (hemp compounds) and the Endocannabinoid System (Human Bio-Communication System) supports the functions of the entire system. Think of "modulation." Or the story of Goldilocks and the 3 Bears. Not too big, not too little.... just right.

TRP channels (including the pain-relevant TRPV1, TRPA1, TRPV3, etc.) are expressed in both the epidermis and dermis of human skin—not confined to a single layer. TRP? ----> These channels are sensory. (Think cold, warm, stinging, pain) They live within the skin layers. They are found on keratinocytes (non-neuronal skin cells) and on peripheral sensory nerve endings, plus some immune and adnexal cells. This distribution explains why topical CBD (which penetrates the stratum corneum into viable skin layers) can directly interact with them for localized pain, inflammation, and spasm relief, as discussed earlier (e.g., via TRPV1 desensitization and ECS modulation in the 2019 TMD trial) Source Paper 📃 in the comments 👇

Topical CBD (cannabidiol) has been studied for its potential to relieve localized pain and reduce inflammation when applied directly to the skin. Unlike oral CBD, topical formulations (creams, gels, oils, or balms) aim for localized effects with minimal systemic absorption, avoiding psychoactivity from THC and liver absorption (in oral CBD). Research includes preclinical (animal) models and small human clinical trials, primarily for conditions like arthritis, neuropathy, and musculoskeletal pain. Source Paper in the Links📄